Cargando…

Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones

BACKGROUND: Ghrelin is an orexigenic stomach hormone that acts centrally to increase mid-brain dopamine neurone activity, amplify dopamine signaling and protect against neurotoxin-induced dopamine cell death in the mouse substantia nigra pars compacta (SNpc). In addition, ghrelin inhibits the lipopo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beynon, Amy L, Brown, M Rowan, Wright, Rhiannon, Rees, Mark I, Sheldon, I Martin, Davies, Jeffrey S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614890/ https://www.ncbi.nlm.nih.gov/pubmed/23509933 http://dx.doi.org/10.1186/1742-2094-10-40

Ejemplares similares

The orexigenic hormone acyl-ghrelin increases adult hippocampal neurogenesis and enhances pattern separation
por: Kent, Brianne A., et al.
Publicado: (2015)

Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease
por: Rees, Daniel, et al.
Publicado: (2022)

Vesicular expression and release of ATP from dopaminergic neurons of the mouse retina and midbrain
por: Ho, Tracy, et al.
Publicado: (2015)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
por: Xu, Zhimin, et al.
Publicado: (2017)

Dopaminergic agonist pramipexole improves memory and increases IL-10 production in LPS-challenged rats
por: Mihaylova, Anita, et al.
Publicado: (2021)

Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson’s Disease in Rats
por: Chen, Guangxin, et al.
Publicado: (2017)

Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction
por: Suda, Yukari, et al.
Publicado: (2018)

Ghrelin in Central Neurons
por: Ferrini, F, et al.
Publicado: (2009)

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson’s disease
por: Zhao, Yi, et al.
Publicado: (2018)

Commentary: Ghrelin promotes midbrain neural stem cells differentiation to dopaminergic neurons through the Wnt/β-catenin pathway
por: Gayden, Jenesis D., et al.
Publicado: (2020)

Ghrelin Stimulation of Growth Hormone-Releasing Hormone Neurons Is Direct in the Arcuate Nucleus
por: Osterstock, Guillaume, et al.
Publicado: (2010)

Live Imaging of Synaptic Vesicle Release and Retrieval in Dopaminergic Neurons
por: Mani, Meera, et al.
Publicado: (2009)

Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons
por: Wang, Danling, et al.
Publicado: (2008)

Ghrelin Indirectly Activates Hypophysiotropic CRF Neurons in Rodents
por: Cabral, Agustina, et al.
Publicado: (2012)

Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
por: Dantas, Vitor G.L., et al.
Publicado: (2011)

The dopaminergic control of Cushing’s syndrome
por: Pivonello, R., et al.
Publicado: (2022)

New Metabolic Influencer on Oxytocin Release: The Ghrelin
por: Szabó, Renáta, et al.
Publicado: (2019)

Calcitriol Imparts Neuroprotection In Vitro to Midbrain Dopaminergic Neurons by Upregulating GDNF Expression
por: Orme, Rowan P., et al.
Publicado: (2013)

Dopaminergic neurons inhibit striatal output via non-canonical release of GABA
por: Tritsch, Nicolas X., et al.
Publicado: (2012)

Sexually dimorphic neuronal inputs to the neuroendocrine dopaminergic system governing prolactin release
por: Esteves, Francisco F., et al.
Publicado: (2019)

Linkage of cDNA expression profiles of mesencephalic dopaminergic neurons to a genome-wide in situ hybridization database
por: Alavian, Kambiz N, et al.
Publicado: (2009)

Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
por: Fernández-Santiago, Rubén, et al.
Publicado: (2019)

Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function
por: Teng, Yan, et al.
Publicado: (2021)

Unacylated Ghrelin Suppresses Ghrelin-Induced Neuronal Activity in the Hypothalamus and Brainstem of Male Rats
por: Stevanovic, Darko M., et al.
Publicado: (2014)

Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson’s Disease Models
por: Huang, Bingxu, et al.
Publicado: (2017)

Dose‐dependent effect of mesenchymal stromal cells co‐grafted with dopaminergic neurons in a Parkinson's disease rat model
por: Rodriguez‐Pallares, Jannette, et al.
Publicado: (2021)

An antagonist of growth hormone-releasing hormone protects against LPS-induced increase of bronchoalveolar lavage fluid protein concentration
por: Akhter, Mohammad S., et al.
Publicado: (2022)

Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab
por: Magiera, Michal, et al.
Publicado: (2011)

Efficient Reprogramming of Mouse Fibroblasts to Neuronal Cells including Dopaminergic Neurons
por: Oh, Seung-ick, et al.
Publicado: (2014)

Midbrain dopaminergic neurons generate calcium and sodium currents and release dopamine in the striatum of pups
por: Ferrari, Diana C., et al.
Publicado: (2012)

Correction: Unacylated Ghrelin Suppresses Ghrelin-Induced Neuronal Activity in the Hypothalamus and Brainstem of Male Rats
Publicado: (2014)

Biased Ghrelin Receptor Signaling and the Dopaminergic System as Potential Targets for Metabolic and Psychological Symptoms of Anorexia Nervosa
por: Khelifa, Mariam S., et al.
Publicado: (2021)

Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice
por: Chien, Chia-Hung, et al.
Publicado: (2016)

Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson’s Disease in Rats
por: He, Dewei, et al.
Publicado: (2018)

Expression of Ghrelin and Its Receptor mRNA in Bovine Oocyte and Cumulus Cells
por: Sirini, Matías Angel, et al.
Publicado: (2019)

Disinhibition Bursting of Dopaminergic Neurons
por: Lobb, Collin J., et al.
Publicado: (2011)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Decreased NAD+ in dopaminergic neurons
por: Sison, Samantha L., et al.
Publicado: (2018)

Interferon-gamma impairs phagocytosis of Escherichia coli by primary murine peritoneal macrophages stimulated with LPS and differentially modulates proinflammatory cytokine release
por: Schütze, Sandra, et al.
Publicado: (2021)

Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
por: Machado, A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_95b72phrpf8o2ihjvdiol0rhe8